Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inuvo (INUV) Total Current Liabilities (2016 - 2025)

Inuvo (INUV) has disclosed Total Current Liabilities for 16 consecutive years, with $14.3 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 20.09% to $14.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.3 million through Dec 2025, down 20.09% year-over-year, with the annual reading at $14.3 million for FY2025, 20.09% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $14.3 million at Inuvo, down from $18.9 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $18.9 million in Q3 2025, with the low at $7.3 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $13.6 million, with a median of $13.8 million recorded in 2022.
  • Peak annual rise in Total Current Liabilities hit 57.89% in 2021, while the deepest fall reached 49.0% in 2021.
  • Over 5 years, Total Current Liabilities stood at $10.7 million in 2021, then grew by 27.51% to $13.6 million in 2022, then grew by 6.89% to $14.5 million in 2023, then rose by 23.08% to $17.9 million in 2024, then fell by 20.09% to $14.3 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $14.3 million, $18.9 million, and $15.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.